Patient
SITE014-0113
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE014 (NLD) (Dr. Moreau)
consented 2026-01-12
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-03-06 (study day 226); relationship: not assessed
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-11-10 (study day 110); relationship: RELATED
Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-11-03 (study day 103); relationship: not assessed
Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-10-31 (study day 100); relationship: NOT RELATED
Grade 2 Thrombocytopenia — outcome: UNKNOWN; onset 2022-10-29 (study day 98); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.